for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Inovio Completes Enrollment In The Phase 1 U.S. Trial Of Ino-4800 For Covid-19 Dna Vaccine Interim Results Expected In June

April 28 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO COMPLETES ENROLLMENT IN THE PHASE 1 U.S. TRIAL OF INO-4800 FOR COVID-19 DNA VACCINE; INTERIM RESULTS EXPECTED IN JUNE

* INOVIO PHARMACEUTICALS INC - INO-4800 PHASE 2/3 U.S. CLINICAL TRIAL BEING PREPARED TO START THIS SUMMER Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up